Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Nathanson

Showing results (181-190 of 528) with videos related to

Pageof 53
Sort By:
Genetics in Medicine Open|December 13, 2024
Customizing the electronic health record for delivery of pharmacogeneticsGlenda Hoffecker, Lisa A Varughese, Joseph Bleznuck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2011
Measurements of tumor cell autophagy predict invasiveness, resistance to chemotherapy, and survival in melanomaXiao-Hong Ma, Shengfu Piao, Dan Wang, et al.
American Journal of Epidemiology|September 7, 2013
Comparison of address-based sampling and random-digit dialing methods for recruiting young men as controls in a case-control study of testicular cancer susceptibilityBartholt Clagett, Katherine L Nathanson, Stephanie L Ciosek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2025
CH Mutations in 16,812 Advanced Cancer Patients-LetterEmmanuel S Antonarakis, Katherine L Nathanson, Kim A Reiss, et al.
Cancer|April 1, 1976
Results of a randomized study comparing DTIC with TIC mustard in malignant melanomaM E Costanza, L Nathanson, W G Costello, et al.
Breast Cancer Research and Treatment|July 18, 2009
Prospective study of breast MRI in BRCA1 and BRCA2 mutation carriers: effect of mutation status on cancer incidenceP Shah, M Rosen, J Stopfer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
Expression of sorafenib targets in melanoma patients treated with carboplatin, paclitaxel and sorafenibLucia Jilaveanu, Christopher Zito, Sandra J Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
The mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor AZD6244 (ARRY-142886) induces growth arrest in melanoma cells and tumor regression when combined with docetaxelNikolas K Haass, Katrin Sproesser, Thiennga K Nguyen, et al.
Archives of Internal Medicine|December 1, 1976
Streptozocin-treated Verner-Morrison Syndrome: plasma vasoactive intestinal peptide and tumor responsesR F Gagel, M E Costanza, R A DeLellis, et al.
Oncogene|January 22, 2013
Human skin neural crest progenitor cells are susceptible to BRAF(V600E)-induced transformationS M Kumar, J Dai, S Li, et al.
Pageof 53

Showing results (181-190 of 528) with videos related to

Sort By:
Pageof 53
Genetics in Medicine Open|December 13, 2024
Customizing the electronic health record for delivery of pharmacogeneticsGlenda Hoffecker, Lisa A Varughese, Joseph Bleznuck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2011
Measurements of tumor cell autophagy predict invasiveness, resistance to chemotherapy, and survival in melanomaXiao-Hong Ma, Shengfu Piao, Dan Wang, et al.
American Journal of Epidemiology|September 7, 2013
Comparison of address-based sampling and random-digit dialing methods for recruiting young men as controls in a case-control study of testicular cancer susceptibilityBartholt Clagett, Katherine L Nathanson, Stephanie L Ciosek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2025
CH Mutations in 16,812 Advanced Cancer Patients-LetterEmmanuel S Antonarakis, Katherine L Nathanson, Kim A Reiss, et al.
Cancer|April 1, 1976
Results of a randomized study comparing DTIC with TIC mustard in malignant melanomaM E Costanza, L Nathanson, W G Costello, et al.
Breast Cancer Research and Treatment|July 18, 2009
Prospective study of breast MRI in BRCA1 and BRCA2 mutation carriers: effect of mutation status on cancer incidenceP Shah, M Rosen, J Stopfer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
Expression of sorafenib targets in melanoma patients treated with carboplatin, paclitaxel and sorafenibLucia Jilaveanu, Christopher Zito, Sandra J Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
The mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor AZD6244 (ARRY-142886) induces growth arrest in melanoma cells and tumor regression when combined with docetaxelNikolas K Haass, Katrin Sproesser, Thiennga K Nguyen, et al.
Archives of Internal Medicine|December 1, 1976
Streptozocin-treated Verner-Morrison Syndrome: plasma vasoactive intestinal peptide and tumor responsesR F Gagel, M E Costanza, R A DeLellis, et al.
Oncogene|January 22, 2013
Human skin neural crest progenitor cells are susceptible to BRAF(V600E)-induced transformationS M Kumar, J Dai, S Li, et al.
Pageof 53